Prostate‐specific membrane antigen (PSMA) is a receptor on the surface of prostate cancer
cells that is revolutionising the way we image and treat men with prostate cancer. New small …

Prostate-specific membrane antigen (PSMA) is expressed in most prostate cancers and can
be identified by PSMA-ligand imaging, which has already become clinically accepted in …

The exposure of the fingers is one of the major radiation protection concerns in nuclear
medicine (NM). The purpose of this paper is to provide an overview of the exposure …

The theranostics concept using the same target for both imaging and therapy dates back to
the middle of the last century, when radioactive iodine was first used to treat thyroid …

METHODS: For this purpose 7 patients who underwent Lu-177-PSMA therapy were
included to the study. The injected Lu-177-PSMA-617 activity was ranged from 3.6 to 7.4 …

Background Prostate-specific membrane antigen (PSMA)-targeted therapy with 177 Lu-
PSMA-617 is a therapeutic option for patients with metastatic castration-resistant prostate …

Purpose To determine the detection rate of PET/CT in biochemical relapse of prostate
cancer using [68 Ga] PSMA I&T and to compare it with published detection rates of [68 Ga] …

To date, several papers have been published about prostate-specific membrane antigen
(PSMA)-based radioligand diagnostic and therapeutic approaches. This paper mainly …

The aim of this narrative review is to evaluate the current status of 177Lu-PSMA (prostate
specific membrane antigen) therapy for metastatic castration-resistant prostate cancer …

In this study, we explore the interactions of photons, protons, and alpha with matter in the
context of two drugs, MDPLu and EDTMPLu, delving into the interesting field of radiation …